期刊文献+

葛根素口腔崩解片的研制 被引量:2

Preparation of puerarin orally disintegrating tablets
下载PDF
导出
摘要 目的以葛根素为模型药物制备口腔崩解片。方法该研制把崩解时间及沉降容积比为指标,单因素法筛选片剂的处方组成及工艺,并优化制备工艺。结果葛根素口腔崩解片的辅料为甘露醇、明胶、阿司帕坦与薄荷香精,经过冷冻干燥方法制备,口感良好,4s的崩解时间,在4min内体外溶出度达96.46%。结论葛根素口腔崩解片可迅速崩解于口腔内,制备工艺可行。 Objective To develop oral disintegrating tablets with puerarin as themodeldrug .Methods The develop-ment selected the disintegration time and sedimentation volume ratio as an indicator .Screened tablet formulation consisting and process of single factor method .Optimized the preparation process .Results Puerarin orally disintegrating tablets were pre-pared by lyopyilization,containing the inactive ingredient:mannitol,gelatin,aspartame and mint flavor.The prepared tablets tas-ted fine and could disintegrate in 4s.The in vitro dissolution test indicated that 96.46%of puerarin dissolved in 4 minutes from the oral disintegrating tablets .Conclusion The prepared of puerarin oral disintegrating tablets disintegrated rapidly in oral cavity,the process of preparation is feasible .
作者 向程
出处 《临床合理用药杂志》 2015年第16期1-2,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 葛根素 口腔崩解片 冷冻干燥法 沉降容积 崩解时间 Puerarin Orally disintegrating tablets Lyopyilization Sedimentation volume Disintegration time
  • 相关文献

参考文献5

二级参考文献22

  • 1姬玉萍,张艳.卡马西平的不良反应[J].四川精神卫生,2007,20(1). 被引量:4
  • 2翟光喜,王海刚,凌沛学,张天民.口腔崩解片质量评价与临床应用研究进展[J].中国新药杂志,2007,16(12):926-929. 被引量:28
  • 3国家食品药品监督管理局药品审评中心.口腔崩解片的剂型特点和质量控制会议纪要[EB/OL].http://www.cde.org.cn.2003-09-25.2004-01-27. 被引量:3
  • 4Morita Y, Tsusima Y, Yasui M, et al. Evaluation of disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera[J]. Chem Pharm Bull, 2002, 50(9):1 181. 被引量:1
  • 5审评四部药学组.有关速释片、口腔速溶片及口腔崩解片的会议纪要[DB/OL].http://www.ede.org.cn/dzkw.do?method=largePagc&id=1362.2002—05—22.2008—11-19. 被引量:1
  • 6罗永煌,田朋鑫,等.甲磺酸普立地诺口腔崩解片及其制备方法[P].中国:CN101664393.2010-03-10. 被引量:2
  • 7Svensson P, Wang K, Arendt-Nielsen L. Effect of muscle relaxants on experimental jaw-muscle pain and jaw-stretch reflexes: a double-blind and placebo-controlled trial [J]. Eur JPain, 2003,7 (5) : 449. 被引量:1
  • 8Pipino F, Menarini C, Lombardi G. et al. A direct myotonolytic (pridinol mesilate) for the management of chronic low back pain: A multicentre, comparative clinical evaluation[J]. Eur J Clin Res , 1991,1 (5):55. 被引量:1
  • 9Oertel WH, Dodel RC. International guide to drugs for Parkinson' s disease[J]. Mov Disord, 1995,10( 2 ) : 121. 被引量:1
  • 10日本厚生劳动省公定书协会.日本药局方外医药品规格[S].2002年版.东京:Jiho株式会社,2002:207. 被引量:1

共引文献15

同被引文献50

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部